Vivani Medical
VANI
28 hedge funds and large institutions have $7.18M invested in Vivani Medical in 2024 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 4 closing their positions.
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
12% more funds holding
Funds holding: 25 → 28 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.8% less ownership
Funds ownership: 11.16% → 10.36% (-0.8%)
32% less call options, than puts
Call options by funds: $97K | Put options by funds: $142K
37% less capital invested
Capital invested by funds: $11.4M → $7.18M (-$4.17M)
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$86.1K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$62.7K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$44.1K |
| 4 |
BlackRock
New York
|
+$26.2K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$24.7K |
Top Sellers
VANI Hedge Fund Activity: Q2 2024 in Review
28 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q2 2024, worth a combined $7.18M — down 37% from $11.4M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new VANI positions and 4 closed out — a net gain of 3 holders — while 7 added to existing stakes and 6 trimmed.
The largest buyer was Vanguard Group, adding an estimated $86.1K. The largest seller was Sabby Management, cutting an estimated $937K.
- 28 institutional investors held Vivani Medical (VANI) as of Q2 2024, up from 25 in Q1 2024.
- Funds reported $7.18M of Vivani Medical stock for Q2 2024, down 37% quarter-over-quarter.
- 7 funds opened new Vivani Medical positions in Q2 2024 and 4 closed out, a net change of +3 holders.
- The largest Vivani Medical buyer in Q2 2024 was Vanguard Group, an estimated $86.1K added.
- The largest Vivani Medical seller in Q2 2024 was Sabby Management, an estimated $937K sold.
Based on aggregated 13F filings for Q2 2024.